Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. 1986 Mar; 83(6): 1660–1664.
PMCID: PMC323143

Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site.


Human acid beta-glucosidase (D-glucosyl-N-acylsphingosine glucohydrolase, EC cleaves the glucosidic bonds of glucosylceramide and synthetic beta-glucosides. The deficient activity of this hydrolase is the enzymatic defect in the subtypes and variants of Gaucher disease, the most prevalent lysosomal storage disease. To isolate and characterize the catalytic site of the normal enzyme, brominated 3H-labeled conduritol B epoxide (3H-Br-CBE), which inhibits the enzyme by binding covalently to this site, was used as an affinity label. Under optimal conditions 1 mol of 3H-Br-CBE bound to 1 mol of pure enzyme protein, indicating the presence of a single catalytic site per enzyme subunit. After V8 protease digestion of the 3H-Br-CBE-labeled homogeneous enzyme, three radiolabeled peptides, designated peptide A, B, or C, were resolved by reverse-phase HPLC. The partial amino acid sequence (37 residues) of peptide A (Mr, 5000) was determined. The sequence of this peptide, which contained the catalytic site, had exact homology to the sequence near the carboxyl terminus of the protein, as predicted from the nucleotide sequence of the full-length cDNA encoding acid beta-glucosidase.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Gatt S, Rapport MM. Isolation of beta-galactosidase and beta-glucosidase from brain. Biochim Biophys Acta. 1966 Mar 7;113(3):567–576. [PubMed]
  • Furbish FS, Blair HE, Shiloach J, Pentchev PG, Brady RO. Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3560–3563. [PMC free article] [PubMed]
  • Strasberg PM, Lowden JA, Mahuran D. Purification of glucosylceramidase by affinity chromatography. Can J Biochem. 1982 Nov;60(11):1025–1031. [PubMed]
  • Grabowski GA, Dagan A. Human lysosomal beta-glucosidase: purification by affinity chromatography. Anal Biochem. 1984 Aug 15;141(1):267–279. [PubMed]
  • Dale GL, Villacorte DG, Beutler E. Solubilization of glucocerebrosidase from human placenta and demonstration of a phospholipid requirement for its catalytic activity. Biochem Biophys Res Commun. 1976 Aug 23;71(4):1048–1053. [PubMed]
  • Berent SL, Radin NS. Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein). Biochim Biophys Acta. 1981 Jun 23;664(3):572–582. [PubMed]
  • Gatt S, Dinur T, Osiecki K, Desnick RJ, Grabowski GA. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase. Enzyme. 1985;33(2):109–119. [PubMed]
  • Grabowski GA, Gatt S, Kruse J, Desnick RJ. Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites. Arch Biochem Biophys. 1984 May 15;231(1):144–157. [PubMed]
  • Erickson JS, Radin NS. N-hexyl-O-glucosyl sphingosine, an inhibitor of glucosyl ceramide -glucosidase. J Lipid Res. 1973 Mar;14(2):133–137. [PubMed]
  • Grabowski GA, Dinur T, Osiecki KM, Kruse JR, Legler G, Gatt S. Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine. Am J Hum Genet. 1985 May;37(3):499–510. [PMC free article] [PubMed]
  • Grabowski GA, Goldblatt J, Dinur T, Kruse J, Svennerholm L, Gatt S, Desnick RJ. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients. Am J Med Genet. 1985 Jul;21(3):529–549. [PubMed]
  • Glew RH, Daniels LB, Clark LS, Hoyer SW. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease. J Neuropathol Exp Neurol. 1982 Nov;41(6):630–641. [PubMed]
  • Ginns EI, Brady RO, Pirruccello S, Moore C, Sorrell S, Furbish FS, Murray GJ, Tager J, Barranger JA. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5607–5610. [PMC free article] [PubMed]
  • Quaroni A, Semenza G. Partial amino acid sequences around the essential carboxylate in the active sites of the intestinal sucrase-isomaltase complex. J Biol Chem. 1976 Jun 10;251(11):3250–3253. [PubMed]
  • Quaroni A, Gershon E, Semenza G. Affinity labeling of the active sites in the sucrase-isomaltase complex from small intestine. J Biol Chem. 1974 Oct 25;249(20):6424–6433. [PubMed]
  • Bause E, Legler G. Isolation and structure of a tryptic glycopeptide from the active site of beta-glucosidase A3 from Aspergillus wentii. Biochim Biophys Acta. 1980 Dec 16;626(2):459–465. [PubMed]
  • Bause E, Legler G. Isolation and amino acid sequence of a hexadecapeptide from the active site of beta-glucosidase A3 from Aspergillus wentii. Hoppe Seylers Z Physiol Chem. 1974 Apr;355(4):438–442. [PubMed]
  • Sorge J, West C, Westwood B, Beutler E. Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7289–7293. [PMC free article] [PubMed]
  • Radin NS. Preparation of psychosines (1-O-hexosyl sphingosine) from cerebrosides. Lipids. 1974 May;9(5):358–360. [PubMed]
  • Dinur T, Grabowski GA, Desnick RJ, Gatt S. Synthesis of a fluorescent derivative of glucosyl ceramide for the sensitive determination of glucocerebrosidase activity. Anal Biochem. 1984 Jan;136(1):223–234. [PubMed]
  • Legler G. Glucosidases. Methods Enzymol. 1977;46:368–381. [PubMed]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • Wray W, Boulikas T, Wray VP, Hancock R. Silver staining of proteins in polyacrylamide gels. Anal Biochem. 1981 Nov 15;118(1):197–203. [PubMed]
  • Hunkapiller MW, Hewick RM, Dreyer WJ, Hood LE. High-sensitivity sequencing with a gas-phase sequenator. Methods Enzymol. 1983;91:399–413. [PubMed]
  • Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982 May 5;157(1):105–132. [PubMed]
  • Corrigan AJ, Huang PC. A BASIC microcomputer program for plotting the secondary structure of proteins. Comput Programs Biomed. 1982 Dec;15(3):163–168. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Drapeau GR. The primary structure of staphylococcal protease. Can J Biochem. 1978 Jun;56(6):534–544. [PubMed]
  • Legler G, Harder A. Amino acid sequence at the active site of beta-glucosidase A from bitter almonds. Biochim Biophys Acta. 1978 May 11;524(1):102–108. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • Gene
    Gene links
  • GEO Profiles
    GEO Profiles
    Related GEO records
  • HomoloGene
    HomoloGene links
  • MedGen
    Related information in MedGen
  • OMIM
    OMIM record citing PubMed
  • Protein
    Published protein sequences
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...